Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART - Test2 - elhamkhani - TriplyDB

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

http://www.wikidata.org/entity/Q28476094

about

Approaches to preventative and therapeutic HIV vaccines Mucociliary dysfunction in HIV and smoked substance abuse Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines Developments in HIV-1 immunotherapy and therapeutic vaccination.Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication.Induction of antibodies and T cell responses by a recombinant influenza virus carrying an HIV-1 TatΔ51-59 protein in mice.The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge Interferon-alpha administration enhances CD8+ T cell activation in HIV infection Challenges in HIV Vaccine Research for Treatment and Prevention.HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies The grafting of universal T-helper epitopes enhances immunogenicity of HIV-1 Tat concurrently improving its safety profile.The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.IL-7 receptor recovery on CD8 T-cells isolated from HIV+ patients is inhibited by the HIV Tat protein Expression of the IL-7 receptor alpha-chain is down regulated on the surface of CD4 T-cells by the HIV-1 Tat protein HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial HIV RNA suppression and immune restoration: can we do better?Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.HIV Infects Bronchial Epithelium and Suppresses Components of the Mucociliary Clearance Apparatus.Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.HIV-1 Tat B-cell epitope vaccination was ineffectual in preventing viral rebound after ART cessation: HIV rebound with current ART appears to be due to infection with new endogenous founder virus and not to resurgence of pre-existing Tat-dependent v HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice.Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.The effects of HIV Tat DNA on regulating the immune response of HIV DNA vaccine in mice.Lessons learned from HIV vaccine clinical efficacy trials.Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).Therapeutic vaccines against HIV infection.Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine.New challenges in therapeutic vaccines against HIV infection.Identification of a highly conserved surface on Tat variants.Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.Clustered epitopes within a new poly-epitopic HIV-1 DNA vaccine shows immunogenicity in BALB/c mice.The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders."cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".Aptamers in HIV research diagnosis and therapy.

P2860

Q26764851-BEA225D9-938F-4433-ACC8-0B3932EA5DB2 Q26777222-19B33E07-9602-40BE-A5AA-AA950EA7B73B Q27333734-69A5723F-3B9A-4C5C-857F-8365FAD8B502 Q30364312-1077280F-B91A-47C3-AEB9-48AC8417BAFF Q33603602-E5155751-DE81-4E32-B912-90383FA809F8 Q33739129-5C446749-9916-4194-9EDD-EF6D00EE93DA Q33864926-15E4EDE4-4AC2-44BB-A5C9-DC41637BCB6C Q33916162-652EDF2D-B90A-4532-B73E-2C3E367D62EC Q34145979-ABA5A25A-2EDD-4EC8-B57F-E1F669F8723D Q34148683-461C4C24-3F69-4D75-91D2-4B43852819B5 Q34477471-1FCB5677-C08C-466D-A227-3C09784D664A Q34756847-28A97814-5825-4326-AF36-25AE4CDA73B4 Q35040673-6310C94E-EB5C-4A32-975C-9C5E4F598DB9 Q35208314-61D1AA5F-0283-4459-A24D-6E93F8A50BC0 Q35354848-8856B5FB-B1CE-4CF3-A056-CE369F87E56A Q35552889-BEC4D523-FB48-43E4-85EB-1BBB26C9994B Q35867173-957B5365-5731-4699-8357-D1AC3658B09D Q36083803-447B5414-5E6F-4538-8EDA-68E406026982 Q36109585-A542F0F6-3B2D-40F0-BDE3-FDDB1A538E88 Q36242915-94DA8353-174D-452A-B8B6-DB5D2AAD58E8 Q36605014-4ED05699-CD17-4A53-B7DE-93E71B3D1276 Q36827396-4FB1F5ED-1860-4ADE-9BF2-BB6E841CCDE6 Q36864918-00B5C554-4AA6-4652-B689-56DA50469051 Q36986644-551A4989-697A-4D71-A603-3611FDED1205 Q37054470-00E78D27-F127-4B27-8CA7-D3516CB602AB Q37104090-047335B2-D048-4DC0-A653-30C1B9FC737A Q37153763-C2A6191D-6D07-41DC-8544-C4170074677A Q37364423-36BAFD9A-DBC0-461D-BDC7-0AB9A9092BB2 Q37724091-846A55B2-B6B8-4A9B-81B1-52FA1F7BD722 Q37967232-14206AF4-3037-481B-92D2-5732DD350D49 Q38013505-F2AE52A3-35E9-4146-8595-12EA04AC9807 Q38212101-6E7FA531-C84D-4772-BDB2-89847C224C02 Q38533881-5816AADE-7CD5-4C5F-8353-F04579D39FA9 Q38692205-D1411269-45ED-463F-B6A8-4AD6FA925E48 Q41468434-98554670-7D3A-4EBE-B2EE-C61437747990 Q42061242-CC7ACFB4-18D1-43FD-8B0E-F1D62AB6C3A8 Q42217775-6B3B938F-D8D0-4B30-BC8F-0757B9F0175C Q42253045-8C1F5D5C-DCAF-4F43-8C73-06BB0148F9F0 Q46698274-1EF86403-2BFA-4016-9959-CF7BF6ED94C3 Q50066811-12099009-1A5D-4BDC-96E8-67B8C5DE8013

P2860

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

http://www.wikidata.org/entity/Q28476094

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Therapeutic immunization with ...... function in subjects on HAART

@ast

Therapeutic immunization with ...... function in subjects on HAART

@en

Therapeutic immunization with ...... function in subjects on HAART

@nl

type

label

Therapeutic immunization with ...... function in subjects on HAART

@ast

Therapeutic immunization with ...... function in subjects on HAART

@en

Therapeutic immunization with ...... function in subjects on HAART

@nl

prefLabel

Therapeutic immunization with ...... function in subjects on HAART

@ast

Therapeutic immunization with ...... function in subjects on HAART

@en

Therapeutic immunization with ...... function in subjects on HAART

@nl

P1433

Q28476094-ACD075B2-7F61-44F3-BA44-4DB7D2CBBC1A

P1476

Q28476094-A22CF14B-E052-45B1-AC3B-2F86DFC21CF5

P2093

Q28476094-0C7B7FC5-685D-4061-A049-45706001D566

Q28476094-0D5E70A3-28FD-459E-B3A3-F52DED11EAF6

Q28476094-120E149A-C00E-421F-8289-B4D2E274A61B

Q28476094-1F893F24-0DD8-462A-8331-9E1530EE2E29

Q28476094-2E9E4601-9EE2-417A-8969-6D770A47F686

Q28476094-354B85C0-4D37-4368-BCC4-CF8CFA33442C

Q28476094-3E597C41-E6FD-4F62-9D73-7AE6A253BEC3

Q28476094-461F8236-CD22-4AA6-87A0-1DF25CBB792E

Q28476094-4FF82241-8E2D-4898-9F76-5BF4DC8CF54C

Q28476094-84CC0ADA-6768-429F-82D1-970158574866

P2860

Q28476094-0394F867-BCA0-4AAC-9DE0-81531A744CA0

Q28476094-03FAFC58-D5C6-4ACD-8EE9-869197F36A2E

Q28476094-04399BA9-FB21-4722-AF1A-E930288854F7

Q28476094-049E41D2-F088-4567-882E-0EC69F8E5F5A

Q28476094-0CEF0F76-3ACF-4401-9A95-868DF59B2285

Q28476094-125043F1-1B7A-443A-8F87-3236B308908A

Q28476094-131E0596-F7B1-4F16-8C08-8FB3DB9DFAF1

Q28476094-1DF5A2AE-A7E0-420A-9888-4941DAB04341

Q28476094-1FD900E7-3282-49CD-9371-F9675C3EB9DD

Q28476094-20A48CFE-45C7-44EB-9672-8CD0645FC665

P304

Q28476094-7C8C2C56-9019-4A63-8961-F8ADF66C3FBF

P31

Q28476094-45DFA0D9-84C2-44C9-B924-2F159EB56A30

P3181

Q28476094-BD9AFBBD-2A75-4A77-A5A2-E3414ED89046

P356

Q28476094-42A0F0B3-0DA5-44B9-93CE-10743977F2D9

P407

Q28476094-05DB87CC-F9D6-4E85-A868-106FD86063BF

P433

Q28476094-0EC809F0-FD7D-4A26-9A42-71F9641F4FD3

P478

Q28476094-EE76BC3B-AD79-4D8D-953C-5FE917C605C3

P50

Q28476094-02F81CFA-66A7-4F0B-9E61-600D4E049361

Q28476094-048CC448-AD18-46BB-B794-261A49C27C5A

Q28476094-107D046D-500B-4FDA-AF3B-1BD19A53111D

Q28476094-23B8D87A-7A69-460D-BAEB-80A7DC2FA816

Q28476094-24E209D2-1715-4019-84F8-EAD413D898B8

Q28476094-3E851F44-7532-4B6C-AAA0-8D8AE38B6DD9

Q28476094-45944955-B380-4A6B-901A-4DCA3AFE1EE8

Q28476094-5823ED8B-D5CD-4660-8B46-9ADFA6C83870

Q28476094-A0A30483-9C0E-4097-8A58-EAE8199FB9C9

Q28476094-AB682D98-5EBD-4EBE-8494-9FA74BBC2B4B

P577

Q28476094-C365130D-686E-4CF1-B511-DA55556D6DF9

P5875

Q28476094-68BB5BBB-0C1D-468D-96C8-D7EE7373AEFF

P698

Q28476094-6733B1FE-C1EB-48D3-B85D-4CA5C86D4E61

P921

Q28476094-7434B9BD-94B3-49D2-BC5D-915ACBB92C55

P932

Q28476094-0B1844AB-D3DE-425E-9E79-35189C0816DD

P3181

P356

JOURNAL.PONE.0013540

P1433

P1476

Therapeutic immunization with ...... function in subjects on HAART

@en

P2093

Angela Arancio

http://www.w3.org/2001/XMLSchema#string

Antonella Tripiciano

http://www.w3.org/2001/XMLSchema#string

Arianna Scoglio

http://www.w3.org/2001/XMLSchema#string

Aurelio Cafaro

http://www.w3.org/2001/XMLSchema#string

Cristina Ariola

http://www.w3.org/2001/XMLSchema#string

Cristina Iori

http://www.w3.org/2001/XMLSchema#string

Cristina Mussini

http://www.w3.org/2001/XMLSchema#string

Donato Scaramuzzi

http://www.w3.org/2001/XMLSchema#string

Enrico Garaci

http://www.w3.org/2001/XMLSchema#string

Fabrizio Soscia

http://www.w3.org/2001/XMLSchema#string

P2860

Immune activation and inflammation in HIV-1 infection: causes and consequences

The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein

Tat protein induces self-perpetuating permissivity for productive HIV-1 infection

Quantifying the uncertainty in forecasts of anthropogenic climate change

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation

Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction

The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation

[21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction

P304

e13540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

336655

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0013540

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Nicoletta Ladisa

Giampiero Carosi

Laura Sighinolfi

Orietta Picconi

Stefano Rusconi

Giuseppe Tambussi

Alessandra Latini

Fabrizio Ensoli

P577

2010-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47812924

http://www.w3.org/2001/XMLSchema#string

P698

21085635

http://www.w3.org/2001/XMLSchema#string

P921

P932

2978690

http://www.w3.org/2001/XMLSchema#string